| Literature DB >> 33499647 |
Elizabeth W Regan1, Reed Handlery1, Jill C Stewart1, Joseph L Pearson2, Sara Wilcox1, Stacy Fritz1.
Abstract
Background Cardiac rehabilitation (CR) is a structured exercise program prevalent in the United States for people with cardiovascular disease that has been shown to increase cardiovascular endurance and improve quality of life. Despite similar cardiovascular risk factors, stroke is not among the covered diagnoses for CR. The purpose of this study was to examine the participant impact of integrating survivors of stroke into the exercise portion of an existing hospital-based CR program through measures of physical function and other health impacts and through qualitative evaluation of participant perception. Methods and Results Subacute and chronic survivors of stroke were integrated into a standard 12-week, 3 sessions per week, exercise-based CR program. A total of 29 began the program, 24 completed the program, and 18 were available for 6-month follow-up. Quantitative measures were compared preprogram with postprogram with t-test or equivalent, and preprogram with postprogram to 6-month follow-up with ANOVA or equivalent. Semistructured interviews were completed with 11 participants postprogram. Exercise-based CR had significant impacts on cardiovascular endurance preprogram to postprogram, with maintenance at 6-month follow-up. The participants improved on the 6-minute walk test on average by 61.92 m(95% CI, 33.99-89.84 m), and maximum metabolic equivalents improved by a median of 3.6 (interquartile range, 2.35). Five times sit to stand (functional strength) improved preprogram to postprogram by a median of 2.85 s (interquartile range, 4.03 s). Qualitative findings highlight additional health improvements. Most participants (83% [15/18]) reported continued exercise at follow-up. Conclusions Exercise-based CR has the potential to improve cardiovascular endurance, health status, and quality of life for survivors of stroke. Registration URL: https://www.clinicaltrials.gov; Unique identifier: NCT03706105.Entities:
Keywords: cardiac rehabilitation; exercise; stroke; stroke rehabilitation
Year: 2021 PMID: 33499647 PMCID: PMC7955427 DOI: 10.1161/JAHA.120.017907
Source DB: PubMed Journal: J Am Heart Assoc ISSN: 2047-9980 Impact factor: 5.501
Figure 1Study flowchart.
COVID‐19 indicates coronavirus disease 2019; Phone, telephone; and Rehab, rehabilitation.
Outcome Measures
| Outcome Measure | Assessment |
|---|---|
| 6‐min Walk test |
Cardiovascular endurance; walking capacity; initial fitness in CR programs Measured as distance in meters |
| 5 Times sit to stand test |
Functional lower body strength Measured as seconds to complete |
| 10‐m Walk test |
Self‐selected and fast walking speed Measured as m/s |
| Maximum METs |
Standard measure of exercise tolerance and functional capacity in CR programs Measured from 1 (very low) to 13 (very high) fitness |
| Activities‐Specific Balance Confidence Scale |
Self‐perception of balance confidence Total score, 0%–100% confidence A score <67% indicates an increased risk of falls |
| Stroke Impact Scale |
Impact of stroke on 8 domains: mobility, participation, activities of daily living, hand function, strength, communication, emotion, and memory/thinking Domain subscores from 0% (significant impact) to 100% (no impact) |
| Short Self‐Efficacy for Exercise and Short Outcome Expectations for Exercise Scales |
Confidence to complete exercise behaviors, such as exercising alone or through fatigue Exercise outcome expectations, such as belief that exercise improves mood or improves endurance Scores are from 1 (low) to 5 (high) |
| Patient Health Questionnaire‐9 |
Depression Total score of 0–27, with categories of 0 (no depression), 1–9 (minimum to mild depression), 10–14 (moderate depression), and 15–27 (moderately severe to severe depression) |
CR indicates cardiac rehabilitation; and MET, metabolic equivalent task.
Maximum METs were calculated at the initial visit and final visits as part of the standard program and were not reassessed at 6‐month follow‐up.
Demographics of Program Participants
| Variable | Completers (n=24) | Noncompleters (n=5) |
|---|---|---|
| Sex, % (n) | ||
| Men | 79 (19) | 60 (3) |
| Women | 21 (5) | 40 (2) |
| Age, mean (SD), y | 62.2 (12.4) | 68.4 (15.0) |
| Race/ethnicity, % (n) | ||
| White | 71 (17) | 60 (3) |
| Black | 25 (6) | 40 (2) |
| Asian | 4 (1) | |
| Type of stroke, % (n) | ||
| Ischemic | 65 (15) | 40 (2) |
| Hemorrhagic | 12.5 (3) | 40 (2) |
| Unknown | 25 (6) | 20 (1) |
| Time since stroke, mean (SD), mo | 29.7 (29.9) | 37.0 (41.8) |
| Initial 6MWT distance category, % (n) | ||
| ≥288 m | 83.3 (20) | 40 (2) |
| <288 m | 16.7 (4) | 40 (2) |
| No 6MWT | 20 (1) | |
| Initial SSWS, mean (SD), m/s | 1.17 (0.21) | 0.67 (0.28) |
| Preprogram exercise level, % (n) | ||
| None | 12.5 (3) | 40 (2) |
| <1× wk | 12.5 (3) | 0 (0) |
| 1–3× wk | 37.5 (9) | 60 (3) |
| >3× wk | 37.5 (9) | 0 (0) |
6MWT indicates 6‐minute walk test; and SSWS, self‐selected walking speed.
Stroke type was self‐reported by participant.
The 6MWT ≥288 m indicates community ambulator status.
Results Preprogram to Postprogram: Paired t‐Test Outcome Measures
| Test | No. | Proprogram, Mean (SD) | Postprogram, Mean (SD) | Change, Mean (SD) | 95% CI of Mean Change | t | df | Significance (P Value) | Effect Size (d) |
|---|---|---|---|---|---|---|---|---|---|
| 6MWT, m | 24 | 397.80 (119.23) | 459.71 (118.46) | ↑ 61.92 (66.13) | 33.99–89.84 | 4.587 | 23 | <0.001 | 0.94 |
| FWS, m/s | 23 | 1.50 (0.42) | 1.59 (0.50) | ↑ 0.09 (0.18) | 0.02–0.17 | 3.167 | 22 | 0.019 |
6MWT indicates 6‐minute walk test; and FWS, fast walking speed.
Higher distance indicates an improvement in score.
Greater than the minimal detectable change for stroke of 31 m.
Statistically significant changes.
Higher number indicates a faster walking speed.
Results Preprogram to Postprogram: Wilcoxon Signed Rank Test Outcome Measures
| Test | No. | Preprogam, Median (IQR) | Postprogram, Median (IQR) | Change, Median (IQR) | Z | Significance (P Value) |
|---|---|---|---|---|---|---|
| Cardiovascular endurance measures | ||||||
| SIS‐Mobility (0%–100%) | 24 | 72.22 (31.25) | 77.78 (29.17) | ↑ 6.94 (11.11) | 2.665 | 0.008 |
| MET maximum (1 [low] to 13 [high]) | 24 | 2.95 (0.88) | 6.00 (3.00) | ↑ 3.6 (2.35) | 4.199 | <0.001 |
| Physical function measures | ||||||
| FTSS test, s (lower score is better) | 23 | 14.42 (11.14) | 12.2 (6.47) | ↓ 2.85 (4.03) | −3.528 | <0.001 |
| SSWS, m/s (higher score is faster) | 23 | 1.16 (0.34) | 1.18 (0.38) | ↑ 0.02 (0.16) | 1.095 | 0.274 |
| ABC Scale score, % confidence | 24 | 73.44 (35.28) | 86.38 (21.48) | ↑ 1.78 (14.61) | 1.686 | 0.092 |
| SIS‐Physical (0%–100%) | 24 | 62.50 (37.50) | 75.00 (37.50) | − 0.00 (18.75) | 1.350 | 0.177 |
| Quality‐of‐life measures (SIS‐Other subscales) | ||||||
| SIS‐Mood (0%–100%) | 24 | 77.78 (29.17) | 86.11 (20.14) | ↑ 4.17 (13.19) | 1.869 | 0.062 |
| SIS‐Memory (0%–100%) | 24 | 78.57 (37.50) | 82.14 (27.68) | − 0.00 (16.96) | 2.076 | 0.038 |
| SIS‐Communication (0%–100%) | 24 | 87.50 (50.00) | 83.93 (31.25) | − 0.00 (13.39) | 1.623 | 0.105 |
| SIS‐ADL (0%–100%) | 24 | 90.00 (31.25) | 90.00 (16.90) | ↑ 2.50 (9.38) | 2.425 | 0.013 |
| SIS‐Hand (0%–100%) | 24 | 85.00 (43.75) | 92.50 (40.00) | − 0.00 (10.00) | 1.002 | 0.316 |
| SIS‐Participation (0%–100%) | 24 | 70.31 (53.91) | 76.56 (39.06) | ↑ 3.13 (21.09) | 1.976 | 0.048 |
| SIS‐Recovery (0%–100%) | 24 | 80.00 (15.00) | 82.50 (15.00) | ↑ 5.00 (10.00) | 1.715 | 0.086 |
| Self‐efficacy measures (exercise and outcome expectations) | ||||||
| SSEE Scale (1 [low] to 5 [high]) | 22 | 4.20 (1.19) | 4.50 (0.69) | ↑ 0.25 (1.06) | 2.023 | 0.043 |
| SOEE Scale (1 [low] to 5 [high]) | 22 | 4.00 (0.60) | 4.20 (1.60) | ↑ 0.20 (0.65) | 2.397 | 0.017 |
ABC indicates Activities‐Specific Balance Confidence; ADL, activities of daily living; FTSS, 5 times sit to stand; IQR, interquartile range; MET, metabolic equivalent task; SIS, Stroke Impact Scale; SOEE, Short Outcome Expectations for Exercise; SSEE, Short Self‐Efficacy for Exercise; and SSWS, self‐selected walking speed.
↑ Indicates improvement, ↓ indicates decline, and − indicates no change.
Change is greater than the clinically important difference rate of 4.5%.
Statistically significant changes <0.01.
Change is greater than the 1.14‐s minimal detectable change for survivors of stroke.
SIS‐ADL change score distribution was not symmetrical, so a sign test was completed instead of Wilcoxon signed rank test.
Figure 2Changes over time.
A, Improvements over time in mean 6‐minute walk test (6MWT) distance, ANOVA, n=18 (P=0.001), effect size 0.41. *Indicates 66.51‐m change (95% CI, 12.80–120.24 m): P=0.013. **Indicates 71.67‐m change (95% CI, 26.19–117.15 m): P=0.002. 6MWT distance mean (SD) preprogram, 403.18 m (108.34 m); postprogram, 474.85 m (101.49 m); and 6‐month follow‐up, 469.70 m (26.17 m). Error bars are SD. B, Improvements over time in the 5 times sit to stand (FTSS) test time in pairwise comparisons, Friedman test, n=17 (P<0.001). Faster time indicates a better score. Box plots show median, interquartile range, minimum, and maximum. FTSS median test time (interquartile range) preprogram, 14.23 s (7.15 s); postprogram, 11.88 s (5.44 s); 6‐month follow‐up, 10.75 s (6.92 s). One participant used one upper extremity for support to rise to standing during testing. **P<0.001.